Co., Ltd. (Biocytogen, HKEX: 02315) today announced that the key technology of its independently developed RenMab™ fully ...

Biocytogen secures Japanese patent for RenMab platform; expands global patent portfolio for RenMice fully human antibody: Beijing Saturday, June 7, 2025, 11:00 Hrs [IST] Biocytoge ...

Our ability to provide a voice for scientists and engineers and to advance science depends on the support from individuals like you. Whether you’re a scientist, engineer, teacher, or science advocate, ...

Option Chain is currently not available. Nasdaq provides call and put options information of stocks. Financial analysts and individual investors can rely on the chain to gauge the stock's ...

Expert Rev of Obstet Gynecol. 2012;7(3):269-279. In summary, excess levels of urobilinogen and bilirubin in the urine may signal liver disease, and more research is needed to correlate these ...